Lv5
884 积分 2024-08-30 加入
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
13天前
已完结
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
13天前
已完结
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
15天前
已完结
The Discovery ofTNG456: A Highly Potent, Selective,Brain-Penetrant MTA-Cooperative PRMT5 Inhibitor for the Treatmentof MTAP -Deleted Cancers
23天前
已完结
Exploring structural diversity and dynamic stability of small-molecule PRMT5 inhibitors through machine learning–based QSAR and molecular modelling
23天前
已完结
Multikilogram-Scale Process Development for a Key Intermediate of a Clinical-Stage MTA-Cooperative PRMT5 Inhibitor
23天前
已完结
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluation
23天前
已完结
Structure-Guided Discovery of Novel Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitors
3个月前
已完结
PRMT5: A Promising Synthetical Lethal Target for MTAP-Deleted Cancers
4个月前
已完结
Exploring structural diversity and dynamic stability of small-molecule PRMT5 inhibitors through machine learning–based QSAR and molecular modelling
6个月前
已完结